Výsledky vyhledávání - Murat O. Arcasoy

Upřesnit hledání
  1. 1
    The non‐haematopoietic biological effects of erythropoietin

    The non‐haematopoietic biological effects of erythropoietin Autor Murat O. Arcasoy

    Vydáno 2008
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    A Novel Role for Erythropoietin During Fibrin-Induced Wound-Healing Response

    A Novel Role for Erythropoietin During Fibrin-Induced Wound-Healing Response Autor Zishan A. Haroon, Khalid Amin, Xiaohong Jiang, Murat O. Arcasoy

    Vydáno 2003
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Familial Erythrocytosis Associated With a Short Deletion in the Erythropoietin Receptor Gene

    Familial Erythrocytosis Associated With a Short Deletion in the Erythropoietin Receptor Gene Autor Murat O. Arcasoy, Barbara Degar, Kevin W. Harris, Bernard G. Forget

    Vydáno 1997
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Mechanisms of erythropoietin‐mediated cardioprotection during ischemia‐reperfusion injury: role of protein kinase C and phosphatidylinositol 3‐kinase signaling

    Mechanisms of erythropoietin‐mediated cardioprotection during ischemia‐reperfusion injury: role of protein kinase C and phosphatidylinositol 3‐kinase signaling Autor Paul Hanlon, Ping Fu, Gary L. Wright, Charles Steenbergen, Murat O. Arcasoy, Elizabeth Murphy

    Vydáno 2005
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Erythropoietin Biology in Cancer

    Erythropoietin Biology in Cancer Autor Matthew E. Hardee, Murat O. Arcasoy, Kimberly Blackwell, John P. Kirkpatrick, Mark W. Dewhirst

    Vydáno 2006
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Erythropoietin and Erythropoietin Receptor Expression in Head and Neck Cancer: Relationship to Tumor Hypoxia

    Erythropoietin and Erythropoietin Receptor Expression in Head and Neck Cancer: Relationship to Tumor Hypoxia Autor Murat O. Arcasoy, Khalid Amin, Shu-Chuan Chou, Zishan A. Haroon, Mahesh A. Varia, James A. Raleigh

    Vydáno 2005
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Erythropoietin receptor contributes to melanoma cell survival in vivo

    Erythropoietin receptor contributes to melanoma cell survival in vivo Autor Suresh Kumar, G Zhang, Boris C. Bastian, Murat O. Arcasoy, Pankaj Karande, Anitha Pushparajan, Géza Ács, Xiaowei Xu

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression

    Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression Autor Matthew E. Hardee, Yiting Cao, Ping Fu, Xiaohong Jiang, Yulin Zhao, Zahid N. Rabbani, Željko Vujašković, Mark W. Dewhirst, Murat O. Arcasoy

    Vydáno 2007
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Failure of Terminal Erythroid Differentiation in EKLF-Deficient Mice Is Associated with Cell Cycle Perturbation and Reduced Expression of E2F2

    Failure of Terminal Erythroid Differentiation in EKLF-Deficient Mice Is Associated with Cell Cycle Perturbation and Reduced Expression of E2F2 Autor André M. Pilon, Murat O. Arcasoy, Holly K. Dressman, Serena E. Vayda, Yelena Maksimova, José Sangerman, Patrick G. Gallagher, David M. Bodine

    Vydáno 2008
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    <i>ZCCHC8</i>, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation

    <i>ZCCHC8</i>, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation Autor Dustin L. Gable, Valeriya Gaysinskaya, Christine C. Atik, C. Conover Talbot, Byunghak Kang, Susan E. Stanley, Elizabeth Pugh, Nuria Amat-Codina, Kara M. Schenk, Murat O. Arcasoy, Cory Brayton, Liliana Florea, Mary Armanios

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Lung transplantation in telomerase mutation carriers with pulmonary fibrosis

    Lung transplantation in telomerase mutation carriers with pulmonary fibrosis Autor Leann Silhan, Pali D. Shah, Daniel C. Chambers, Laurie D. Snyder, Gerdt C. Riise, Christa L. Wagner, Eva Hellström-Lindberg, Jonathan B. Orens, Juliette F. Mewton, Sonye K. Danoff, Murat O. Arcasoy, Mary Armanios

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

    American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer Autor J. Douglas Rizzo, Melissa Brouwers, Patricia A. Hurley, Jerome Seidenfeld, Murat O. Arcasoy, Jerry L. Spivak, Charles L. Bennett, Julia Bohlius, Darren M. Evanchuk, Matthew J. Goode, Ann A. Jakubowski, David H. Regan, Mark R. Somerfield

    Vydáno 2010
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  13. 13
    American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer

    American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer Autor J. Douglas Rizzo, Melissa Brouwers, Patricia A. Hurley, Jerome Seidenfeld, Murat O. Arcasoy, Jerry L. Spivak, C. L. Bennett, Julia Bohlius, Darren M. Evanchuk, Matthew J. Goode, Ann A. Jakubowski, David H. Regan, Mark R. Somerfield

    Vydáno 2010
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  14. 14
    ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial

    ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial Autor Stephen T. Oh, Moshe Talpaz, Aaron T. Gerds, Vikas Gupta, Srđan Verstovšek, Ruben A. Mesa, Carole B. Miller, Candido E. Rivera, Angela G. Fleischman, Swati Goel, Mark Heaney, Casey L. O’Connell, Murat O. Arcasoy, Yafeng Zhang, Jun Kawashima, Tomas Ganz, Mark Kowalski, Carrie Baker Brachmann

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Diagnosis of Capnocytophaga canimorsus Sepsis by Whole-Genome Next-Generation Sequencing

    Diagnosis of Capnocytophaga canimorsus Sepsis by Whole-Genome Next-Generation Sequencing Autor Maria K. Abril, Adam S. Barnett, Kara Wegermann, Eric Fountain, Andrew D. Strand, Benjamin Heyman, Britton Blough, Aparna Swaminathan, Batu K. Sharma‐Kuinkel, Felicia Ruffin, Barbara D. Alexander, Chad M. McCall, Sylvia F. Costa, Murat O. Arcasoy, David K. Hong, Timothy A. Blauwkamp, Michael A. Kertesz, Vance G. Fowler, Bryan Kraft

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

    Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I Autor Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, R. S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Azra Raza, Kris Vaddi, William Sun, Wei Peng, V. Sandor, Hagop M. Kantarjian

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

    Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial Autor Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Mark M. Jones, Deanna Kornacki, Kang Sun, Hagop M. Kantarjian

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo‐controlled, Phase <scp>III</scp> study in patients with myelofibrosis

    The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo‐controlled, Phase <scp>III</scp> study in patients with myelofibrosis Autor Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson‐Viitanen, William Sun, Victor Sandor, Hagop M. Kantarjian

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

    Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors Autor Mohamed Shanavas, Uday Popat, Laura C. Michaelis, Veena Fauble, Donal P. McLornan, Rebecca B. Klisovic, John Mascarenhas, Roni Tamari, Murat O. Arcasoy, James Davies, Usama Gergis, Oluchi C. Ukaegbu, Rammurti T. Kamble, John M. Storring, Navneet S. Majhail, Rizwan Romee, Srđan Verstovšek, Antonio Pagliuca, Sumithira Vasu, Brenda Ernst, Eshetu G. Atenafu, Ahmad Hanif, Richard Champlin, Parameswaran Hari, Vikas Gupta

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I

    Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I Autor Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John Catalano, Michael W. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, E. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson‐Viitanen, William Sun, V. Sandor, H. Kantarjian

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: